Evidence map›Paper›PMID 33587293›Full record

ArticleAlcoholism, clinical and experimental research2021

Blood Biomarkers of Intestinal Epithelium Damage Regenerating Islet-derived Protein 3α and Trefoil Factor 3 Are Persistently Elevated in Patients with Alcoholic Hepatitis.

Jing Yang, Fahim Syed, Ying Xia, Arun J Sanyal, Vijay H Shah, Naga Chalasani, Xiaoqun Zheng, Qigui Yu, Yongliang Lou, Wei Li

Open access · greenAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. A Novel Sesquiterpene fromMolecules (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jing YangSchool of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Fahim SyedDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Ying XiaSchool of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Arun J SanyalDivision of Gastroenterology and Hepatology, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
Vijay H ShahDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Naga ChalasaniDivision of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Xiaoqun ZhengDepartment of Clinical Laboratory, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Qigui YuDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Yongliang LouSchool of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Wei LiDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.ORCID 0000-0003-4026-314X
Indiana University School of MedicineWenzhou Medical University · CNMayo Clinic · USVirginia Commonwealth University · US

Funding

Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)U01AA021840 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI NAGA P CHALASANI, Olawale Ojo · 2012 to 2026
$8.1M
TREAT-MayoU01AA021788 · NIAAA · MAYO CLINIC ROCHESTER · PI MALHI, HARMEET, SHAH, VIJAY H. · 2012 to 2022
$4.7M
Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) – Mayo ClinicU01AA026974 · NIAAA · MAYO CLINIC ROCHESTER · PI VICTOR M. KARPYAK, VIJAY H. SHAH · 2018 to 2026
$2.9M
Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) - Virginia Commonwealth UniversityU01AA026979 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Juan Pablo Arab Verdugo, FREDERICK Gerard MOELLER · 2018 to 2026
$2.9M
TREAT-VCUU01AA021891 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI SANYAL, ARUN J · 2012 to 2017
$2.5M
Alcohol's impact on immunological and virological profiles in HIV patientsUH3AA026218 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI YU, QIGUI A. · 2019 to 2021
$963k
Alcohol's impact on immunological and virological profiles in HIV patientsUH2AA026218 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI YU, QIGUI A. · 2017 to 2018
$318k
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-ADMIN)U01AA021883 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI CRABB, DAVID W · 2012 to 2017
$229k
NIAAA NIH HHS U01 AA021788NIAAA NIH HHS U01 AA021840NIAAA NIH HHS U01 AA021883NIAAA NIH HHS U01 AA021891NIAAA NIH HHS U01 AA026974NIAAA NIH HHS U01 AA026979NIAAA NIH HHS UH2 AA026218NIAAA NIH HHS UH3 AA026218
6 · The paper itself

Abstract

backgroundHeavy alcohol consumption disrupts gut epithelial integrity, leading to increased permeability of the gastrointestinal tract and subsequent translocation of microbes. Regenerating islet-derived protein 3α (REG3α) and Trefoil factor 3 (TFF3) are mainly secreted to the gut lumen by Paneth and Goblet cells, respectively, and are functionally linked to gut barrier integrity. Circulating levels of REG3α and TFF3 have been identified as biomarkers for gut damage in several human diseases. We examined whether plasma levels of REG3α and TFF3 were dysregulated and correlated with conventional markers of microbial translocation (MT) and pro-inflammatory mediators in heavy drinkers with and without alcoholic hepatitis (AH).

methodsCross-sectional and longitudinal studies were performed to monitor plasma levels of REG3α and TFF3 in 79 AH patients, 66 heavy drinkers without liver disease (HDC), and 46 healthy controls (HC) at enrollment and at 6- and 12-month follow-ups. Spearman correlation was used to measure the relationships of REG3α and TFF3 levels with MT, disease severity, inflammation, and effects of abstinence from alcohol.

resultsAt enrollment, AH patients had significantly higher levels of REG3α and TFF3 than HDC and HC. The elevated REG3α levels were positively correlated with the 30-day fatality rate. Plasma levels of REG3α and TFF3 in AH patients differentially correlated with conventional MT markers (sCD14, sCD163, and LBP) and several highly up-regulated inflammatory cytokines/chemokines/growth factors. At follow-ups, although REG3α and TFF3 levels were decreased in AH patients with alcohol abstinence, they did not fully return to baseline levels.

conclusionsCirculating levels of REG3α and TFF3 were highly elevated in AH patients and differentially correlated with AH disease severity, MT, and inflammation, thereby serving as potential biomarkers of MT and gut epithelial damage in AH patients.

Indexed as

Bacterial TranslocationAdultAlcohol AbstinenceBiomarkersCase-Control StudiesFemaleHepatitis, AlcoholicHumansInflammationInterleukin-22InterleukinsIntestinal MucosaMaleMiddle AgedPancreatitis-Associated ProteinsSeverity of Illness IndexBiomarkersInterleukin-22InterleukinsPancreatitis-Associated ProteinsREG3A protein, humanTFF3 protein, humanTrefoil Factor-3Alcoholic HepatitisGut Epithelial DamageImmune ActivationInflammationMicrobial TranslocationREG3αTFF3

Identifiers

PMID33587293
PMCPMC8076084
OpenAlexW3193088599

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.